Animal models of toxicology testing: the role of pigs

被引:92
|
作者
Helke, Kristi L. [1 ]
Swindle, Marvin Michael [1 ]
机构
[1] Med Univ S Carolina, Charleston, SC 29425 USA
关键词
cytochrome P450; drug metabolism; kidney; liver; pig; skin; toxicology; DRUG-METABOLIZING ACTIVITIES; SUS-SCROFA-DOMESTICA; P-GLYCOPROTEIN MDR1; IN-VITRO METABOLISM; LIVER-MICROSOMES; CYTOCHROME-P450; ENZYMES; MINIATURE PIGS; UDP-GLUCURONOSYLTRANSFERASES; XENOBIOTIC METABOLISM; ORAL BIOAVAILABILITY;
D O I
10.1517/17425255.2013.739607
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: In regulatory toxicological testing, both a rodent and non-rodent species are required. Historically, dogs and non-human primates (NHP) have been the species of choice of the non-rodent portion of testing. The pig is an appropriate option for these tests based on metabolic pathways utilized in xenobiotic biotransformation. Areas covered: This review focuses on the Phase I and Phase II biotransformation pathways in humans and pigs and highlights the similarities and differences of these models. This is a growing field and references are sparse. Numerous breeds of pigs are discussed along with specific breed differences in these enzymes that are known. While much available data are presented, it is grossly incomplete and sometimes contradictory based on methods used. Expert opinion: There is no ideal species to use in toxicology. The use of dogs and NHP in xenobiotic testing continues to be the norm. Pigs present a viable and perhaps more reliable model of non-rodent testing.
引用
收藏
页码:127 / 139
页数:13
相关论文
共 50 条
  • [31] Introducing the Concept of Virtual Control Groups into Preclinical Toxicology Animal Testing
    Steger-Hartmann, Thomas
    Kreuchwig, Annika
    Vaas, Lea
    Wichard, Joerg
    Bringezu, Frank
    Amberg, Alexander
    Muster, Wolfgang
    Pognan, Francois
    Barber, Chris
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2020, 37 (03) : 343 - 349
  • [32] Animal models in influenza vaccine testing
    van der Laan, Jan Willem
    Herberts, Carla
    Lambkin-Williams, Robert
    Boyers, Alison
    Mann, Alexander J.
    Oxford, John
    EXPERT REVIEW OF VACCINES, 2008, 7 (06) : 783 - 793
  • [33] ZIKA TESTING: ANIMAL MODELS AND ASSAYS
    Graul, A.
    Tremosa, L.
    Dulsat, C.
    DRUGS OF THE FUTURE, 2016, 41 (07) : 423 - 427
  • [34] Toxicology Testing in Pregnancy Evaluating the Role of Social Profiling
    Perlman, Nicola C.
    Cantonwine, David E.
    Smith, Nicole A.
    OBSTETRICS AND GYNECOLOGY, 2020, 136 (03): : 607 - 609
  • [35] Toxicology Testing in Pregnancy: Evaluating the Role of Social Profiling
    Perlman, Nicola C.
    Smith, Nicole A.
    OBSTETRICS AND GYNECOLOGY, 2020, 135 : 38S - 38S
  • [36] THE CHANGING-ROLE OF ANIMAL TOXICOLOGY IN SUPPORT OF REGULATORY DECISIONS
    MILLER, FJ
    GRAHAM, JA
    GARDNER, DE
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1983, 52 (OCT) : 169 - 176
  • [37] Behavioral toxicology of cognition: Extrapolation from experimental animal models to humans Behavioral toxicology symposium overview
    Paule, Merle G.
    Green, Leonard
    Myerson, Joel
    Alvarado, Maria
    Bachevalier, Jocelyne
    Schneider, Jay S.
    Schantz, Susan L.
    NEUROTOXICOLOGY AND TERATOLOGY, 2012, 34 (02) : 263 - 273
  • [38] ANIMAL MODELS OF BURNS AND SCARRING: FROM MICE TO PIGS
    McMillan, J. R.
    Kimble, R. M.
    WOUND REPAIR AND REGENERATION, 2010, 18 (04) : A75 - A75
  • [39] A novel nasal powder formulation of glucagon: toxicology studies in animal models
    Reno, Frederick E.
    Normand, Patrick
    McInally, Kevin
    Silo, Sherwin
    Stotland, Patricia
    Triest, Myriam
    Carballo, Dolores
    Piche, Claude
    BMC PHARMACOLOGY & TOXICOLOGY, 2015, 16
  • [40] An Analysis of the Use of Animal Models in Predicting Human Toxicology and Drug Safety
    Bailey, Jarrod
    Thew, Michelle
    Balls, Michael
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2014, 42 (03): : 181 - 199